We are receiving strong commercial interest not only in our rapid antigen test but also for the multiplex COVID-19/Flu A/B variant and the Sepis test both of which we anticipate progressing once more resources are available.
That part is interesting, BOD obviously expects more resources to be available in Q1 next year on the heels of successful events unfolding over the next 2 months.
Wording is not IF but ONCE,
all IMO
Ann: AGM - Chairman's Address, page-5
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.77M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.2¢ | $19.37K | 880.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1191253 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 245576 | 1 |
View Market Depth
| Last trade - 15.51pm 02/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |